{"id":"tp-60916","type":"article-newspaper","title":"XTL Biopharmaceuticals Posts $0.00 GAAP EPS for First Half","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/60916","datePublished":"2026-11-18T22:46:56.000Z","dateModified":"2026-11-18T22:46:56.000Z","language":"en","abstract":"Cash and cash equivalents were approximately $1.80 million at June 30, 2026, up from approximately $0.08 million on Dec. 31, 2025.","section":"Business","references":[]}